Quoin Pharmaceuticals (QNRX) Net Cash Flow (2021 - 2026)
Quoin Pharmaceuticals (QNRX) posted Net Cash Flow of -$694027.0 for Q1 2026, down 134.91% sequentially from $2.0 million in Q4 2025, and down 449.15% YoY from $198779.0 in Q1 2025.
Quoin Pharmaceuticals (QNRX) Net Cash Flow (2021 - 2026) Analysis & Trends
Quoin Pharmaceuticals has reported Net Cash Flow for 6 years, with the latest figure at -$694027.0 in Q1 2026.
- Quarterly Net Cash Flow fell 449.15% year-over-year to -$694027.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$697440.0 (down 135.07% YoY) and the FY2025 annual result came in at $195366.0, down 84.01% from the prior year.
- Net Cash Flow fell to -$694027.0 in Q1 2026 per QNRX's latest filing, from $2.0 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $2.6 million in Q3 2022 and troughed at -$2.5 million in Q2 2022.
- A 5-year average of -$256358.3 and a median of $181904.0 in 2025 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2022 and 2026: Net Cash Flow surged 339.93% in 2022, then tumbled 449.15% in 2026.
- Over 5 years, Net Cash Flow stood at -$2.4 million in 2022, then surged by 68.1% to -$762228.0 in 2023, then surged by 166.46% to $506593.0 in 2024, then surged by 292.39% to $2.0 million in 2025, then tumbled by 134.91% to -$694027.0 in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$694027.0, $2.0 million, and $181904.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -496,000.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -37.14 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 225.59 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -2.83 Bn |
| 10 | Quoin Pharmaceuticals | 491,038.58 | 491,038.58 | - | 721,506.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -694,027.00 |
| Mar 31, 2026 | -694,027.00 |
| Dec 31, 2025 | 1.99 Mn |
| Dec 31, 2025 | 1.99 Mn |
| Sep 30, 2025 | 181,904.00 |
| Sep 30, 2025 | 181,904.00 |
| Jun 30, 2025 | -2.17 Mn |
| Jun 30, 2025 | -2.17 Mn |
| Mar 31, 2025 | 198,779.00 |
| Mar 31, 2025 | 198,779.00 |
| Dec 31, 2024 | 506,593.00 |
| Dec 31, 2024 | 506,593.00 |
| Sep 30, 2024 | 271,624.00 |
| Sep 30, 2024 | 271,624.00 |
| Jun 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | -567,674.00 |
| Mar 31, 2024 | -567,674.00 |
| Dec 31, 2023 | -762,228.00 |
| Dec 31, 2023 | -762,228.00 |